192 to 124. No Medication. Here's the Mechanism.

By Tom Mackey

May 18, 2026

I want to share the research I found — because after my quarterly panel came back at LDL 124, I've had more people ask me what I actually did than I can respond to individually. The mechanism is the part that matters. Not the product. The mechanism. Once you understand it, everything else makes sense.

Where I Am Now

LDL 124. Total cholesterol 196.

Four months ago I was sitting in a doctor's office holding a prescription for Atorvastatin, being told that refusing it would be documented as non-compliance against medical advice. Today I have quarterly monitoring, no statin, and numbers that ended the conversation before it started.

I'm not a researcher. I'm a 58-year-old man who spent two nights going down a hole in the research because I was out of options. What I found in those two nights explained everything that had failed before it — and it had nothing to do with diet, supplements, or willpower.

I want to lay out the mechanism. All of it. Because if you're reading this, you probably need to understand it the same way I did.

This condition is called hepatic insulin resistance, and in women in perimenopause, it is far more common than it is discussed.

The 80% Nobody Talks About

Start here: your liver produces roughly 80% of the cholesterol in your body.

Not your diet. Your liver.

I did not know this. After years of watching what I ate — oat fiber, omega-3s, cutting saturated fat, reading every label — I did not know that diet accounts for only about 20% of your total cholesterol load. The other 80% is manufactured internally, by your liver, independent of what you eat.

I found this in a physiology textbook excerpt. Basic endocrinology. It wasn't buried in some obscure journal or hidden behind a paywall. It was the kind of foundational information that shows up when you stop searching "how to lower cholesterol" and start searching "why does the liver produce cholesterol."

My doctor never said this to me. In eleven minutes, Dr. Okafor told me my LDL was 192, cited a list of cardiovascular risks, and handed me a prescription. What she didn't say — what nobody had ever said to me in any of those appointments over the years — was that the organ producing most of my cholesterol was my liver, not my kitchen.

Think about what that means.

I had been modifying my diet for years. Measured portions. Consistent exercise. Bloodwork every six months. And my numbers kept climbing anyway. 2021: LDL 148. 2022: LDL 158. 2023: LDL 167. 2024: LDL 178.

Then 192.

The trajectory was clear and it had nothing to do with how careful I was being at the dinner table.

Because I was working on the 20%.

My liver was producing four times that amount, completely unregulated, and I was spending all my effort on the fraction I could actually see — the food on my plate. I used to think the analogy of bailing water out of a boat was too simple. But that's exactly what I was doing. Bailing hard. Taking it seriously. Real effort, real consistency. And the boat kept filling because nobody had told me there was a hole in the hull.

The question that changed everything was this: if diet controls only 20%, what controls the 80%?

I'd never thought to ask it. I'd never heard anyone ask it in a doctor's office. Every conversation I'd ever had about cholesterol was about diet, exercise, and medication. The possibility that my liver was operating outside the reach of all three of those things had never come up.

Once I asked the question, the answer was in the literature. And it had a name.

Adiponectin — The Missing Signal

Adiponectin is a hormone produced by fat tissue. You can look it up in any endocrinology reference — it's not fringe, not contested, not new. It's been studied for decades and its role in metabolic regulation is well established.

Here's what it does, as best as I understand it from the research I read: adiponectin acts as a regulatory signal for the liver's lipid metabolism.

When adiponectin levels are normal, the liver has a functioning brake on cholesterol production. It self-regulates. It responds to feedback.

When adiponectin declines, that brake weakens. The liver produces cholesterol more freely, with less self-correction.

This is where it gets important: adiponectin declines with age. Not dramatically, not suddenly, but steadily. The research suggests it's one of the reasons cholesterol tends to rise as people get older — even in people who haven't changed their diet, haven't gained significant weight, and are otherwise doing everything right.

I want to be honest about what I don't know. The exact mechanism of why adiponectin declines is not fully settled. Some researchers hypothesize it's linked to a loss of specific dietary polyphenol compounds — EGCG, theaflavins, catechins — that decline in modern diets as people age. The theory is that without those compounds, adiponectin production drops and the liver loses part of its regulatory signal. I found this hypothesis in multiple papers, but I'm not a scientist and I can't tell you it's proven. What I can tell you is that it explained something no other explanation had explained: why my cholesterol kept rising despite years of doing the right things on the dietary side.

Here's the part that frustrated me most when I read it: statins don't restore adiponectin.

Statins work by inhibiting an enzyme in the liver called HMG-CoA reductase. They block cholesterol production at the enzymatic level. They're effective at that specific task — the clinical evidence is clear.

But they don't address the regulatory signal. They don't raise adiponectin. They suppress the output, not the dysfunction causing it.

I'm not saying statins are wrong. I'm saying that the mechanism Dr. Okafor never mentioned — the reason my liver was overproducing cholesterol in the first place — is something statins don't address. You take the statin, you suppress the number. You stop the statin, the number comes back. Because the underlying signal hasn't been restored.

The supplements I'd tried didn't address it either. For different reasons, which I'll get to. But the pattern was the same: every approach I'd taken — dietary, pharmaceutical, supplemental — was aimed at the output. None of it was aimed at the signal.

That's what was missing. The signal.

Enjoy 50% off only today!

Why Everything I Tried Failed

Six weeks of red yeast rice. Eight weeks of pharmaceutical-grade fish oil. A full lipid support stack — red yeast rice, plant sterols, niacin, fish oil — from a specialty supplement store.

The results: LDL 189, then basically unchanged, then 186.

Three to six points of movement across twenty-two weeks of consistent effort. The kind of variance that could be measurement noise.

I was confused by this at the time. I'd read the research on these supplements. There's real evidence behind them. Red yeast rice contains naturally occurring statins. Plant sterols reduce dietary cholesterol absorption. Fish oil has documented effects on triglycerides and certain lipid markers. These aren't snake oil.

But none of them moved my LDL meaningfully. And once I understood the 80/20 split, I understood why.

They all work on the 20%.

Red yeast rice suppresses hepatic cholesterol synthesis via the same enzymatic pathway as pharmaceutical statins — but at much lower doses, which is why the effect is modest and inconsistent. Plant sterols compete with dietary cholesterol for intestinal absorption — they reduce what comes in from food. Fish oil works on triglycerides and has indirect effects on certain LDL particle sizes. All of it is dietary-fraction work.

I was bailing water out of the same bucket, just with different tools.

My liver was the problem. My liver was producing cholesterol independent of what I ate, at a rate my dietary interventions couldn't offset. And every supplement I tried — every dollar I spent, every morning I took the pills without fail — was aimed at the 20% while the 80% ran without correction.

This is not a knock on those supplements. For someone whose cholesterol is driven primarily by dietary intake, they might work well. But for someone like me, whose liver had been steadily producing more cholesterol for years despite a careful diet, they were the wrong tool for the wrong problem.

The mechanism had to be addressed at the source.

What Whole-Leaf Oolong Actually Does

When I started searching for what raises adiponectin, exercise came up first. There's solid evidence that sustained aerobic activity increases adiponectin levels. I was already walking four miles a day. Whatever benefit I was getting from exercise, I had it.

Weight loss can raise adiponectin significantly. I'm 184 pounds at five-eleven. The weight-loss pathway wasn't available to me at meaningful levels.

Sleep, stress reduction, intermittent fasting — I read through all of it. Some modest evidence. None of it scaled to the kind of regulatory shift I was looking at.

Then I started finding dietary compounds.

The polyphenols kept appearing in the adiponectin literature. EGCG, theaflavins, catechins — not in supplement marketing, but in actual peer-reviewed trials. Researchers were noting these compounds in connection with adiponectin signaling across multiple independent studies.

I looked at isolated extracts first. Green tea extract. Resveratrol. Grape seed extract. All of them showed some effect on adiponectin in controlled settings. But the effect sizes were small — 4%, 6%, inconsistent across studies. The researchers kept noting something that I initially skimmed past: isolated compounds didn't produce the same effect as whole-plant sources. The hypothesis was that the compounds interact in their natural matrix in ways that isolates can't replicate — that the synergy between EGCG, theaflavins, catechins, and the flavonoids present in whole-plant sources produces an effect that no single extract can match.

That led me to the paper in the Journal of Nutritional Biochemistry.

Japanese university research team — not a supplement company, not a wellness organization. They had been studying the polyphenol composition of traditionally processed oolong tea and its effects on adiponectin signaling in hyperlipidemic adults. Sample size: 94 subjects. Duration: eight weeks. I checked those numbers twice.

The oolong group saw adiponectin levels increase by 12%. LDL reduction averaged 16%. Liver fat metabolism markers normalized across the board.

The mechanism they described: these compounds, in their complete natural form, directly stimulated adiponectin production. Not by blocking cholesterol synthesis. Not by reducing dietary absorption. By restoring the regulatory signal — the one that tells the liver when to stop.

I kept pulling papers. A 2019 randomized controlled trial published in Nutrition Research: 186 subjects, twelve weeks. Mean LDL reduction of 21 points in the treatment group versus 4 in control. Then a 2022 meta-analysis in Atherosclerosis that pooled eleven trials, over 900 subjects total. The effect was consistent across age groups, across baseline LDL levels, and across different oolong preparations. The mean reduction in adiponectin-mediated LDL across the pooled trials was statistically significant and clinically meaningful.

This was not fringe science. This was peer-reviewed research sitting in nutrition and metabolic journals that nobody in a standard clinical appointment had ever mentioned to me.

Why Quality Matters

I bought oolong tea bags from the grocery store that weekend. Three dollars. Janet found the box on the counter.

"Tea? Since when do you drink tea?"

"Since now. Maybe."

I drank it for a week. Then I went back to the research and found what I'd skimmed past the first time.

The studies that showed results weren't using grocery-store tea. They specified whole leaf, traditionally processed, high-altitude grown. One paper was explicit about why: machine harvesting and high-heat drying — the standard commercial process — degraded the polyphenol content dramatically. EGCG, theaflavins, catechins are heat-sensitive.

The industrial process that makes tea cheap and shelf-stable destroys the compounds that matter therapeutically.

Grocery-store tea bags are largely tea dust. Broken bits, floor sweepings, fragments from machine processing. The polyphenol matrix that the research was studying doesn't survive that process intact.

It explained why the three-dollar box did nothing. It didn't explain where to find the real thing.

At 4 AM I searched: oolong tea cholesterol adiponectin whole leaf

One brand kept appearing in the forums where people were clearly doing the same research I was doing. Not wellness blogs. People posting lipid panels. People citing studies. People tracking month over month with their own bloodwork.

Evana Tea.

Whole leaf oolong. Organic. Grown above 4,500 feet. Hand-picked at peak harvest. Traditional low-temperature processing that preserves the full polyphenol matrix at therapeutic concentrations. No dust, no fillers, no pesticides.

It matched what the research specified. That was the bar I was trying to clear.

I ordered it that night.

What Happened to My Numbers

Week four after starting Evana Tea, I drove to a walk-in lab and ordered my own lipid panel.

LDL: 168. Down from 192.

Twenty-four points. I read the report twice. Checked the date. Checked my name.

Week seven. Same lab, same panel.

LDL: 149. Total cholesterol: 228.

Below 160 — below the threshold that had put the prescription in my hand in the first place. I sat in the parking lot for a while before I drove home.

Two days before my appointment with Dr. Okafor, I had my pre-visit labs drawn. The results were in my chart before she walked in.

She opened my file. Stopped.

"LDL 141. Total cholesterol 216."

She looked at 192. Then 141.

"You started the Atorvastatin?"

"No."

"No?"

I told her what I'd found. The 80/20 split. Adiponectin. The Journal of Nutritional Biochemistry trial — 94 subjects, eight weeks. The Nutrition Research RCT. The 2022 meta-analysis in Atherosclerosis. I offered to email her everything. I'd saved all of it.

She read for a while. Then: "Continue what you're doing. Back in twelve weeks. If it holds below 160, quarterly monitoring. No statin."

That was four months ago.

My last quarterly panel: LDL 124. Total cholesterol 196.

192 → 168 → 149 → 141 → 124.

No medication. No compliance flag. Quarterly monitoring with a doctor who has stopped arguing because there's nothing to argue with.

If You Want to Try This

The research is real. The mechanism is documented. The citations exist in journals you can look up yourself — Journal of Nutritional Biochemistry, Nutrition Research, Atherosclerosis. I'm not a scientist and I'm not asking you to take my word for any of it.

What I'd suggest: don't start with blind faith. Start with your own baseline.

Get a lipid panel at a walk-in lab before you begin. Week four, go back. Week eight, go back. Track the numbers yourself. Walk into your next appointment with your own data instead of waiting for your doctor's schedule to tell you whether something worked.

That's what I did. The numbers are the only thing that changed Dr. Okafor's mind. They'll be the only thing that changes yours too.

If you want to start where I started, the specific product I used is at evanatea.com/products/evana-tea. Whole leaf, grown above 4,500 feet, traditionally processed. They offer a 90-day guarantee — if it doesn't work for you, you haven't lost anything.

Steep it three minutes in hot water. Every morning. Then go get your own numbers.

90 days. Your own lipid panel at week four. Then again at week eight.

Then walk into your next appointment with the data.

— Tom Mackey

Evana Tea — Whole-Leaf Oolong To Support Natural Cholesterol Clearance

Available exclusively through Evana Tea's website · Free US shipping on all orders

90-Days Money Back Guarantee!

Get Evana Tea - 90 Day Money-back guarantee

Title